Maria-Grazia De Simoni

Maria-Grazia De Simoni

Auto-generated profile, based on publicly available information

Maria-Grazia De Simoni

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy

Research Focus & Metrics

Academic Career Length

45Years (1982-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 1999 in Journal of Neuroscience
Verified
Journal Article
Open access
AVAnnamaria Vezzani
Annamaria Vezzani
MCMirko Conti
Mirko Conti
ALAda De Luigi
Ada De Luigi
TRTeresa Ravizza
Teresa Ravizza
DMDaniela Moneta
Daniela Moneta
MSMaria Grazia De Simoni
Maria Grazia De Simoni
Using immunocytochemistry and ELISA, we investigated the production of interleukin (IL)-1β in the rat hippocampus after focal application of kainic acid inducing electroencephalographic (EEG) seizures and CA3 neuronal cell loss. Next, we studied whether EEG seizures per se induced IL-1β and microglia changes in the hippocampus using bicuculline as a nonexcitotoxic convulsant agent. Finally, to address the functional role of this cytokine, we measured the effect of human recombinant (hr)IL-1β on seizure activity as one marker of the response to kainate.Three and 24 hr after unilateral intrahippocampal application of 0.19 nmol of kainate, IL-1β immunoreactivity was enhanced in glia in the injected and the contralateral hippocampi. At 24 hr, IL-1β concentration increased by 16-fold (p< 0.01) in the injected hippocampus. Reactive microglia was enhanced with a pattern similar to IL-1β immunoreactivity. Intrahippocampal application of 0.77 nmol of bicuculline methiodide, which induces EEG seizures but not cell loss, enhanced IL-1β immunoreactivity and microglia, although to a less extent and for a shorter time compared with kainate. One nanogram of (hr)IL-1β intrahippocampally injected 10 min before kainate enhanced by 226% the time spent in seizures (p< 0.01). This effect was blocked by coinjection of 1 μg (hr)IL-1β receptor antagonist or 0.1 ng of 3-((+)-2-carboxypiperazin-4-yl)-propyl-1-phosphonate, selective antagonists of IL-1β and NMDA receptors, respectively.Thus, convulsant and/or excitotoxic stimuli increase the production of IL-1β in microglia-like cells in the hippocampus. In addition, exogenous application of IL-1β prolongs kainate-induced hippocampal EEG seizures by enhancing glutamatergic neurotransmission.

10 December 2011 in Journal of Neuroinflammation
Verified
Journal Article
Open access
PDF file
CPCarlo Perego
Carlo Perego
SFStefano Fumagalli
Stefano Fumagalli
MSMaria-Grazia De Simoni
Maria-Grazia De Simoni
Background: Emerging evidence indicates that, similarly to what happens for peripheral macrophages, microglia can express different phenotypes depending on microenvironmental signals. In spite of the large literature on inflammation after ischemia, information on M/M phenotype marker expression, their colocalization and temporal evolution in the injured brain is lacking. The present study investigates the presence of microglia/macrophage phenotype markers, their temporal expression, whether they are concomitantly expressed by the same subpopulation, or they are expressed at distinct phases or locations in relation to the ischemic lesion.Methods: Volume of ischemic lesion, neuronal counts and TUNEL staining were assessed in C57Bl/6 mice at 6-12-24-48 h and 7d after permanent occlusion of the middle cerebral artery. At the same time points, the expression, distribution in the lesioned area, association with a definite morphology and coexpression of the microglia/macrophage markers CD11b, CD45, CD68, Ym1, CD206 were assessed by immunostaining and confocal microscopy.Results: The results show that: 1) the ischemic lesion induces the expression of selected microglia/macrophage markers that develop over time, each with a specific pattern; 2) each marker has a given localization in the lesioned area with no apparent changes during time, with the exception of CD68 that is confined in the border zone of the lesion at early times but it greatly increases and invades the ischemic core at 7d; 3) while CD68 is expressed in both ramified and globular CD11b cells, Ym1 and CD206 are exclusively expressed by globular CD11b cells.Conclusions: These data show that the ischemic lesion is accompanied by activation of specific microglia/macrophage phenotype that presents distinctive spatial and temporal features. These different states of microglia/macrophages reflect the complexity of these cells and their ability to differentiate towards a multitude of phenotypes depending on the surrounding micro-environmental signals that can change over time. The data presented in this study provide a basis for understanding this complex response and for developing strategies resulting in promotion of a protective inflammatory phenotype.

1 July 2000 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
MSMaria Grazia De Simoni
Maria Grazia De Simoni
CPCarlo Perego
Carlo Perego
TRTeresa Ravizza
Teresa Ravizza
DMDaniela Moneta
Daniela Moneta
MCMirko Conti
Mirko Conti
AVAnnamaria Vezzani
Annamaria Vezzani

3 October 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AVAnnamaria Vezzani
Annamaria Vezzani
DMD. Moneta
D. Moneta
MCM. Conti
M. Conti
CRC. Richichi
C. Richichi
TRT. Ravizza
T. Ravizza
TBT. Bartfai
T. Bartfai
IL-1β and its endogenous receptor antagonist (IL-1Ra) are rapidly induced by seizures in the rodent hippocampus. Exogenously applied IL-1β prolongs seizures in an IL-1R type I-mediated manner. This effect depends onN-methyl-d-aspartate receptor activation. We report here that intrahippocampal application of recombinant IL-1Ra or its selective endogenous overexpression in astrocytes under the control of glial acidic fibrillary protein promoter potently inhibits motor and electroencephalographic seizures induced by bicuculline methiodide in mice. Accordingly, transgenic mice show a reduced seizure-relatedc-fosmRNA expression in various forebrain areas compared with their wild-type littermates. Recombinant IL-1Ra was ineffective in mice deficient in IL-1R type I, havingper sea delayed onset to generalized convulsions. These results demonstrate that IL-1Ra mediates potent anticonvulsant effects acting on IL-1R type I and suggest that the balance between brain IL-1β and IL-1Ra represents a crucial mechanism to control seizure generalization.

1 June 2002 in Epilepsia
Verified
Journal Article
Open access
PDF file
AVAnnamaria Vezzani
Annamaria Vezzani
DMDaniela Moneta
Daniela Moneta
CRCristina Richichi
Cristina Richichi
MAMarisa Aliprandi
Marisa Aliprandi
SBStephanie J. Burrows
Stephanie J. Burrows
MSM. Grazia De Simoni
M. Grazia De Simoni
Summary:  Purpose: We investigated the changes in the expression of proinflammatory cytokines and related molecules in the rodent hippocampus after the induction of limbic seizures. We then studied the effects of pharmacologic intervention on the interleukin (IL)‐1 system on limbic seizures and the susceptibility to seizures of transgenic mice overexpressing the naturally occurring antagonist of IL‐1 (IL‐1Ra) in astrocytes.Methods: Limbic seizures were induced in rodents by intrahippocampal injection of kainic acid or bicuculline methiodide or by electrical stimulation of the hippocampus causing status epilepticus (SE). Seizure activity was recorded by EEG analysis and behavioral observation according to Racine's scale. Cytokine expression in the hippocampus was studied by reverse transcriptase–polymerase chain reaction (RT‐PCR) followed by Southern blot quantification of the various messenger RNAs (mRNAs) and by immunocytochemistry.Results: We found that limbic seizures rapidly and transiently enhanced IL‐1β, IL‐6, and tumor necrosis factor (TNF)‐α mRNA in the hippocampus with a peak effect at 6 h after SE. Immunoreactivity of the various cytokines was increased in glia. The increase of IL‐1Ra was delayed because the peak effect was observed at 24 h after SE. Moreover, IL‐1Ra was not produced in large excess, as during peripheral inflammation but in a molar ratio to IL‐1β of 1:1. Intrahippocampal injection of IL‐1β worsened seizure activity, whereas IL‐1Ra was a powerful anticonvulsant in various models of limbic seizures. Transgenic mice overexpressing IL‐1Ra in astrocytes were less sensitive to bicuculline‐induced seizures.Conclusions: This study shows that limbic seizures in rodents rapidly and reversibly induce proinflammatory cytokines in glia and suggests that changes in the IL‐1Ra/IL‐1β ratio in brain may represent an effective physiopathologic mechanism to control seizures.

5 August 2015 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GLGemma Llovera
Gemma Llovera
KHKerstin Hofmann
Kerstin Hofmann
SRStefan Roth
Stefan Roth
ASAngelica Salas-Pérdomo
Angelica Salas-Pérdomo
MFMaura Ferrer-Ferrer
Maura Ferrer-Ferrer
ALArthur Liesz
Arthur Liesz
A multicenter preclinical, randomized, controlled trial (pRCT) of a potential stroke treatment in mice demonstrates the feasibility of performing clinical trial–like investigations in animal models.